Paul Knöbl

8.6k total citations · 2 hit papers
159 papers, 5.6k citations indexed

About

Paul Knöbl is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Paul Knöbl has authored 159 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Hematology, 43 papers in Genetics and 43 papers in Immunology. Recurrent topics in Paul Knöbl's work include Platelet Disorders and Treatments (48 papers), Complement system in diseases (39 papers) and Hemophilia Treatment and Research (33 papers). Paul Knöbl is often cited by papers focused on Platelet Disorders and Treatments (48 papers), Complement system in diseases (39 papers) and Hemophilia Treatment and Research (33 papers). Paul Knöbl collaborates with scholars based in Austria, Germany and United States. Paul Knöbl's co-authors include Klaus Lechner, Bernd Jilma, Johanna A. Kremer Hovinga, Marie Scully, Filip Callewaert, Flora Peyvandi, Ingrid Pabinger, Spero R. Cataland, Hilde De Winter and Rosemarie Reiter and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Paul Knöbl

155 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

2019 602 citations Marie Scully, Spero R. Cataland et al. profile →
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

2016 429 citations Flora Peyvandi, Marie Scully et al. profile →

Peers

Countries citing papers authored by Paul Knöbl

Since Specialization

Citations

This map shows the geographic impact of Paul Knöbl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Knöbl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Knöbl more than expected).

Fields of papers citing papers by Paul Knöbl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Knöbl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Knöbl. The network helps show where Paul Knöbl may publish in the future.

Co-authorship network of co-authors of Paul Knöbl

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Knöbl. A scholar is included among the top collaborators of Paul Knöbl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Knöbl. Paul Knöbl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study 2024 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Ulrich J. Sachs, Karolin Trautmann‐Grill, Christian Pfrepper, Paul Knöbl, Richard Greil, Johannes Oldenburg, Wolfgang Miesbach, Katharina Holstein, Hermann Eichler, Patrick Möhnle, (unknown), Christiane Dobbelstein, Robert Klamroth, Andreas Tiede	0
2	Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL 2024 ·Journal of Thrombosis and Haemostasis ·Bert Verbruggen, Nikolaus B. Binder, (unknown), (unknown), Paul Knöbl, (unknown), Gary Moore	1
3	Saliva and urine from persons with hemophilia A trigger coagulation bypassing factor VIII 2023 ·Hämostaseologie ·J. Thaler, (unknown), (unknown), (unknown), Paul Knöbl, Ingrid Pabinger, Wolfram Ruf, (unknown), Cihan Ay	1
4	Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study 2022 ·Journal of Thrombosis and Haemostasis ·Marie Scully, Javier de la Rubia, (unknown), Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero R. Cataland, Paul Coppo, Johanna A. Kremer Hovinga, (unknown), (unknown), Filip Callewaert, Sriya Gunawardena, Julie Lin	14
5	Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura 2021 ·Blood ·(unknown), Lukas Bütikofer, Kenneth D. Friedman, James N. George, Ingrid Hrachovinová, Paul Knöbl, Masanori Matsumoto, (unknown), (unknown), (unknown), (unknown), Katarzyna Aleksandra Jalowiec, Carlo R. Largiadèr, Zoltán Prohászka, György Sinkovits, Jerzy Windyga, Bernhard Lämmle, Johanna A. Kremer Hovinga	41
6	Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study 2017 ·Blood ·Katharina Holstein, (unknown), Paul Knöbl, Christiane Dobbelstein, Wolfgang Miesbach, Michael Spannagl, (unknown), Ute Scholz, Hermann Eichler, Angela Huth‐Kühne, Robert Klamroth, Armin Koch, Andreas Tiede	2
7	Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study 2016 ·Journal of Thrombosis and Haemostasis ·Sonja Werwitzke, Ulrich Geisen, Ulrike Nowak‐Göttl, Hermann Eichler, Brigitte Stephan, (unknown), Katharina Holstein, Robert Klamroth, Paul Knöbl, Angela Huth‐Kühne, (unknown), Andreas Tiede	42
8	New treatment options for thrombotic thrombocytopenic purpura 2016 ·Hämostaseologie ·Paul Knöbl	2
9	Acquired haemophilia: an overview for clinical practice 2015 ·European Journal Of Haematology ·Craig M. Kessler, Paul Knöbl	61
10	A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease 2010 ·Thrombosis and Haemostasis ·(unknown), Petra Jilma‐Stohlawetz, James C. Gilbert, Renta Hutabarat, Paul Knöbl, Bernd Jilma	65
11	Antithrombotic Strategies in Vascular Surgery: Evidence and Practice 2005 ·European Journal of Vascular and Endovascular Surgery ·Afshin Assadian, C. Senekowitsch, Ojan Assadian, (unknown), G Hagmüller, Paul Knöbl	15
12	Stability of coagulation factors in thawed, solvent/detergent‐treated plasma during storage at 4 °C for 6 days 2004 ·Vox Sanguinis ·Christoph Buchta, Michael Felfernig, P Höcker, Maria Macher, Günther F. Körmöczi, Peter Quehenberger, (unknown), Paul Knöbl	40
13	Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse 2003 ·Leukemia ·A. Weltermann, Christa Fonatsch, Oskar A. Haas, Hildegard Greinix, (unknown), Gerlinde Mitterbauer, Ulrich Jäger, Birgit Kainz, Klaus Geißler, Peter Valent, Wolfgang R. Sperr, Paul Knöbl, Ilse Schwarzinger, Andreas Gleiß, Klaus Lechner	51
14	Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption 2003 ·Bone Marrow Transplantation ·Werner Rabitsch, Paul Knöbl, Erika Prinz, Felix Keil, Hildegard Greinix, Peter Kalhs, Nina Worel, Martin Jansen, Walter H. Hörl, Kurt Derfler	26
15	Fludarabine therapy in Waldenström's macroglobulinemia 2000 ·Annals of Hematology ·Renate Thalhammer-Scherrer, Klaus Geißler, Ilse Schwarzinger, Andreas Chott, Heinz Gisslinger, Paul Knöbl, Klaus Lechner, Ulrich Jäger	26
16	Extracorporeal Immunoadsorption for the Treatment of Haemophilia Patients with Inhibitors to Factor VIII or IX 1999 ·Vox Sanguinis ·Paul Knöbl, Kurt Derfler	6
17	Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis 1998 ·Leukemia ·A. Weltermann, Ingrid Pabinger, Klaus Geißler, Ulrich Jäger, Heinz Gisslinger, Paul Knöbl, Sabine Eichinger, (unknown), Peter Valent, Wolfgang Speiser, Ilse Schwarzinger, Christine Mannhalter, Klaus Lechner	13
18	ORAL CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR V LEIDEN 1996 ·British Journal of Haematology ·C. Rintelen, Christine Mannhalter, Helen Ireland, David A. Lane, Paul Knöbl, Klaus Lechner, Ingrid Pabinger	45
19	Ventilation with the combitube during tracheotomy 1994 ·The Laryngoscope ·Christoph Wiltschke, (unknown), Herwig Swoboda, Paul Knöbl, Gabriela Kornek, (unknown), Thomas Staudinger, Michael Frass	11
20	Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation 1991 ·Journal of Thoracic and Cardiovascular Surgery ·Michael Havel, H. Teufelsbauer, Paul Knöbl, (unknown), Péter Jaksch, W. Zwölfer, Markus Müller, Thomas Vukovich	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact